If approved, Evkeeza would be the first and only treatment of its kind to help children as young as 5 years old control dangerously high levels of LDL cholesterol caused by homozygous familial hypercholesterolemia TARRYTOWN, N.Y., Nov. 30, 2022 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the U.S. Food and Drug Administration (FDA) has […]
Other News
SIMPLEX QUANTUM, Inc. Completes US Patent Registration of Electrocardiogram Biometric Authentication Technology
The University of Aizu collaborated on development of the technology designed to help verify individuals’ identity and protect data integrity TOKYO–(BUSINESS WIRE)–SIMPLEX QUANTUM, Inc. has completed registration in the United States of a patent for a system designed to accurately authenticate an individual’s electrocardiogram (ECG) waveform data. Patent US 11,500,975 B2 […]
Philips Signs Research Agreement to Explore New Magnet Technologies
Collaboration with leading material scientists focuses on the use of high-temperature superconductors to make MR imaging more affordable, accessible and sustainable in the future Operating at higher temperatures and eliminating the use of liquid helium during both production and operation could reduce the size, weight and cost of MRI scanners, […]
GE Healthcare’s AIR Recon DL Technology Recognized by Popular Science Magazine in the ‘Best of What’s New’ Awards
AIR Recon DL is GE Healthcare’s pioneering deep-learning based technology that provides for clinical efficiency by enabling shorter scan times with higher resolution in MRI clinical procedures CHICAGO–(BUSINESS WIRE)–GE Healthcare announced today that it was recognized in the annual ‘Best of What’s New’ awards by Popular Science Magazine. The award highlights GE […]
Broadview Ventures Appoints Michael Mendelsohn, MD to its Strategic Advisory Board
BOSTON – November 30, 2022 – Broadview Ventures, a mission-driven, cardiovascular health-focused investment organization, today announced the appointment of Michael E. Mendelsohn, MD to its Strategic Advisory Board. Dr. Mendelsohn is an internationally recognized cardiovascular physician-scientist, industry research leader and biopharma executive with four decades of broad healthcare and medical experience. Dr. Mendelsohn is […]
Soundbite Medical Solutions Announces Issuance of Two New U.S. Patent Further Expanding Coverage of its Shock Wave Technology
MONTREAL–(BUSINESS WIRE)–Soundbite Medical Solutions Inc. (SBMS), a medical device company leveraging its proprietary shock wave technology for the interventional treatment of calcific occlusive peripheral and coronary arterial diseases, today announced that the United States Patent and Trademark Office has issued two additional US patents. Patent No. 11,419,619, entitled “Method and system for […]
Medtronic’s Next-Gen Evolut™ FX TAVR System Shows Significant Improvement in Commissure Alignment in Real World Setting
London Valves 2022: Latest Transcatheter Aortic Valve Replacement Data for Treatment of Aortic Stenosis and Prosthetic Aortic Valve Degeneration Medtronic’s newest generation self-expanding, transcatheter aortic valve replacement (TAVR) system, Evolut™ FX, significantly improved commissure alignment during TAVR procedures compared to earlier generation Evolut systems. A late breaker presentation at PCR […]
UAB Cardiogenomics Clinic and Allelica to perform polygenic risk score clinical implementation study
The Cardiogenomics Clinic at the University of Alabama at Birmingham and Allelica are partnering to perform a clinical implementation study to assess how polygenic risk score integration changes clinical management and health outcomes in a US health system. NEW YORK, Nov. 29, 2022 /PRNewswire/ — The UAB Cardiogenomics Clinic, led by Dr. Pankaj Arora, is […]
Neovasc Announces Progress on COSIRA-II Clinical Trial
VANCOUVER and MINNEAPOLIS, Nov. 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced an update on the COSIRA-II Clinical Trial (“Trial”) status. COSIRA-II is the U.S. Investigational Device Exemption (“IDE”) pivotal clinical trial the Company is executing for the Neovasc Reducer™ (“Reducer”) towards an approval […]
Kestra Medical Technologies Surpasses 100 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System
Insurer Positive Coverage Decisions Announced KIRKLAND, Wash.–(BUSINESS WIRE)–Kestra Medical Technologies announced today that the ASSURE® Wearable Cardioverter Defibrillator (WCD) system is now available in-network to over 100 million insurance plan members across the U.S. The company reached this covered-lives milestone for the ASSURE WCD system less than one year from when the first […]



